ASML Surges 64% Yet Hits Decade-Cheapest Valuation as Investors Question Demand

The Quick Take

• ASML stock has surged 64% yet trades at its cheapest relative valuation in a full decade.
• Investors question ASML's pricing power, tool adoption rates, and capacity growth projections.
• ASML remains the sole supplier of EUV lithography machines critical to advanced chip production.
• Peers AMAT, Samsung, and TSMC are all implicated in the sector-wide repricing dynamic.

ASML's 64% stock surge against a decade-low relative valuation presents a striking paradox in the semiconductor equipment sector. As the only company capable of producing extreme ultraviolet (EUV) lithography machines essential for advanced chip nodes, ASML's structural position remains unrivaled. Yet the market has reset its valuation premium to decade-lows, suggesting investors are pricing in a more challenging near-term demand environment despite the AI-driven chip supercycle narrative that powered ASML's share price appreciation over prior years.

Semiconductor equipment stocks face asymmetric risk as ASML's relative discount signals peer repricing risk across AMAT, Lam Research, and KLA. For TSMC and Samsung as ASML customers, any tool adoption delay translates directly into capacity expansion slippage that ripples into AI infrastructure timelines. Capital flows into the semiconductor equipment sub-sector may rotate toward more defensively valued equipment names, while ASML's market-leading EUV monopoly position could attract long-horizon institutional accumulation if the cheapest-in-a-decade entry level proves durable through Q3 earnings.

The critical watch point is ASML's next earnings call, where EUV shipment guidance and tool utilization rates will clarify whether the valuation gap is a buying opportunity or an early-warning signal. The macro variable that determines this thesis is global chipmaker capital expenditure: if TSMC and Samsung cut 2026-2027 capex in response to softening AI demand, ASML order book contraction would validate the discount. US export control expansion targeting EUV tools to China — ASML's largest single revenue contributor — remains a structural downside risk that the current valuation may not fully price.

Synthesized from 1 source.